Latest Market Access News

Nexsen Limited (ASX:NXN) has completed its Stage 1 ISO 13485 audit, confirming its Quality Management System (QMS) supports clinical validation and regulatory submissions for its diagnostic products, including StrepSure®. The company is progressing toward full certification and alignment with MDSAP requirements to facilitate global market access.

Duratec Limited is set to acquire Newcastle-based Pacific Welding Australia for up to $12 million, boosting its Energy and Mining sector footprint in NSW. The deal enhances Duratec’s self-perform capabilities and access to key Hunter Region clients.

Lumos Diagnostics has secured its largest-ever order for FebriDx® following FDA clearance, signalling a major expansion in the US market opportunity.

Prospect Resources has confirmed a continuous near-surface copper sulphide system over more than 1km at its West Mwombezhi prospect in Zambia, with a maiden resource estimate due in Q2 2026.

Galilee Energy has appointed a US Advisory Board to drive its Gulf Coast oil and gas expansion, targeting low-risk brownfield assets. The company’s maiden Zydeco-1 well in Louisiana is set to spud in Q2 2026, marking a key milestone in its US growth strategy.

Group 6 Metals has extended its offtake agreement with global trader Traxys, locking in a multi-year supply of tungsten concentrate valued at US$1.75 billion. This deal strengthens G6M’s market access amid growing demand for critical minerals.

Sprintex has cleared a key hurdle in a UK water utility procurement process, positioning itself for participation in a £104 billion infrastructure upgrade cycle focused on energy-efficient wastewater treatment.

EBR Systems marked a pivotal transition in 2025 with FDA approval of its WiSE CRT System and the initiation of U.S. commercial implants, generating $1.6 million in revenue. Despite this progress, the company reported a net loss of $48.8 million and completed a significant capital raise to support ongoing growth.

ARC Funds Limited’s trading suspension has been lifted following key announcements about new board appointments, signaling a fresh chapter for the investment manager.

dorsaVi has secured significant commercial and clinical milestones with new elite sports and European clinical partnerships, showcasing its advanced real-time AI sensor technology.

EMVision Medical Devices has secured a $3.8 million R&D tax rebate and gained approval to claim rebates on overseas expenditures, strengthening its financial footing as it advances clinical trials for its neurodiagnostic device.

Alliance Nickel is advancing its NiWest project by exploring vat leaching to reduce capital costs and has completed initial gold drilling at Wanbanna, while continuing offtake talks with Stellantis and considering a NASDAQ listing via de-SPAC.